Reverba: Company Research Report
Company Overview
- Name: Reverba
- Mission: Reverba transforms personal experience into action to improve human health. The company is dedicated to revolutionizing how people view their patient experience by inspiring them and providing pathways to improve the lives of others with shared health conditions.
- Founded: 2002
- Founders: Specific founders not mentioned, but the company was co-founded by Cheryl Lubbert.
- Key People:
- Cheryl Lubbert, Chief Executive Officer
- Christina Hughes, Chief Operating Officer
- Pam Garfield, EVP, Strategy and Innovation
- Scott Wolf, Chief Growth Officer (appointed on October 21, 2024)
- Headquarters:
- 701 Pike Street, Suite 2000, Seattle, WA 98101, USA
- Secondary locations in:
- 332 Springfield Ave, Suite 200, Summit, NJ 07901, USA
- 60 Bloor St W Suite 201, Toronto, ON M4W 3B8, Canada
- Number of Employees: Reverba employees work globally in a hybrid environment, with exact numbers not specified.
- Revenue: No information is available.
- Known For: Reverba is known for leading innovative and compliant patient engagement solutions for biopharmaceutical companies over the past 20 years. It focuses on transforming healthcare through patient-centric initiatives.
Products
- Offerings:
- Patient engagement solutions tailored for commercial and clinical interactions.
- ReverbaLINK®: A platform recognized in the 2024 TITAN Business Awards.
- High-Level Description and Key Features:
- Patient Engagement Solutions: Provides high-touch patient engagement experiences from initial contact to long-term engagement. Utilizes technologies to empower patients and ensure total compliance with data protection standards.
- reverbaBRIDGE®: Supports patients from awareness through enrollment and trial participation.
- Key Features:
- Empowers patient voices during clinical trials.
- Improves recruitment and retention rates.
- Facilitates actionable insights and streamlined operations.
- Clinical Engagement:
- Improves patient experiences and clinical trial success through insights-driven methods.
Recent Developments
- Achievements:
- Reverba was awarded as a Gold Winner of the 2024 TITAN Business Awards in the Business-to-Business category for its innovative platform, ReverbaLINK®.
- Cheryl Lubbert was recognized in the "30 Most Inspiring Leaders to Watch 2024" and won the 2023 Silver Stevie® Award for Women in Business as the “Mentor of the Year.”
- Acquisitions:
- Acquired Six Degrees Worldwide Inc. in April 2024 to expand its expertise in medical communications and bridge gaps between science and patient experiences.
- Appointments:
- Appointed Scott Wolf as Chief Growth Officer in October 2024 to enhance global market reach and business growth.
- Recognition:
- Named one of the top 10 Patient Engagement Solution Providers of 2024 in the Medhealth Review.
- Strategic Insights:
- Engaged in discussions and innovations at the 2024 DPHARM Conference to further enhance patient engagement strategies.
This report encapsulates Reverba's strategic positioning and market influence, underpinned by its commitment to patient engagement in the healthcare arena.
